AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering to unlock the potential of phytocannabinoids in designing medical therapies....
Read More
Michelle Hoiseth, Chief Data Officer for Parexel and Dr. Gunjan Bhardwaj, CEO Innoplexus discuss the importance of access to the latest COVID-19 data. The new COVID-19 Clearinghouse developed in partnership...
Read More
The cost of developing a new drug roughly doubles every nine years (inflation-adjusted) aka Eroom’s law. As the volume of data for drug discovery and development explodes, the ability of Pharma...
Read More
In medicine, a Biomarker is a biological indicator, which can mark a state of a biology and is measurable. A Biomarker or a combination of few biomarkers can establish the...
Read More
Life sciences data coupled with Innoplexus’s AI and data analytics solutions can help researchers accurately pinpoint novel biomarkers. Innoplexus’s proprietary technology provides deep-dive insights to predict biomarker response....
Read More
AI technologies are more widely used in the pharmaceutical industry today to enable for its extensive review of scientific and medical literature. Extensive data obtained through AI can support...
Read More
hbspt.forms.create({
portalId: "4993422",
formId: "3e5820a7-6828-4160-9ecd-a54cdb2a5549"
});
